Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study

The effect of coronavirus disease (COVID-19) on the risk of relapse in multiple sclerosis (MS) have been unknown. In this retrospective study of 41 relapsing-remitting MS patients, number of relapses in pre-defined at risk-period (ARP) was compared with the previous two years. During the previous tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzegar, Mahdi, Vaheb, Saeed, Mirmosayyeb, Omid, Afshari-Safavi, Alireza, Nehzat, Nasim, Shaygannejad, Vahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036166/
https://www.ncbi.nlm.nih.gov/pubmed/33979771
http://dx.doi.org/10.1016/j.msard.2021.102947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036166/
https://www.ncbi.nlm.nih.gov/pubmed/33979771
http://dx.doi.org/10.1016/j.msard.2021.102947

Ejemplares similares